SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-15-007264
Filing Date
2015-08-13
Accepted
2015-08-13 16:33:44
Documents
10
Period of Report
2015-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q cbyl-10q_20150630.htm 10-Q 1509489
2 EX-31.1 cbyl-ex311_201506308.htm EX-31.1 10427
3 EX-31.2 cbyl-ex312_201506307.htm EX-31.2 9668
4 EX-32.1 cbyl-ex321_201506306.htm EX-32.1 8479
  Complete submission text file 0001564590-15-007264.txt   5609569

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT cbyl-20150630.xml EX-101.INS 1051885
6 XBRL TAXONOMY EXTENSION SCHEMA cbyl-20150630.xsd EX-101.SCH 47092
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cbyl-20150630_cal.xml EX-101.CAL 42084
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cbyl-20150630_def.xml EX-101.DEF 194936
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE cbyl-20150630_lab.xml EX-101.LAB 348486
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cbyl-20150630_pre.xml EX-101.PRE 295875
Mailing Address 3181 PORTER DRIVE PALO ALTO CA 94304
Business Address 3181 PORTER DRIVE PALO ALTO CA 94304 650-855-6777
Carbylan Therapeutics, Inc. (Filer) CIK: 0001348911 (see all company filings)

IRS No.: 200915291 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36830 | Film No.: 151051122
SIC: 2834 Pharmaceutical Preparations